Clinical Trials Browser

Phase 1/2 × Recruiting × Vemurafenib × Clear all

NCT01638676 2021-10-29

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Phase 1/2 Recruiting

Melanoma